
Sign up to save your podcasts
Or


A public debate is raging around the regulation of artificial intelligence (AI). One side argues that AI is potentially dangerous and needs to be carefully controlled, whereas the other side argues that any regulation would slow innovation. In this interview, Dr. Ryan Metcalf, section chief of Transfusion Medicine and medical director of Transfusion Service/Blood Bank at ARUP Laboratories, makes a strong case for a safety-first approach to healthcare AI. He also explains why embedding AI development and use within a strong quality management framework could actually lead to more innovation over the long term, even as it prevents patient harm in the short term.
RELATED INFORMATION: Creation and Adoption of Large Language Models in Medicine
The FDA recently announced a plan to regulate laboratory-developed tests (LDTs) as medical devices. In this interview, Dr. Meghan Delaney from Children’s National Hospital and Dr. Eric Konnick from the University of Washington explain why many tests that are critical to patient care, particularly in the areas of pediatrics, transplantation, and rare diseases, may become unavailable if the rule the FDA has proposed is enacted. Other tests may remain available, but at a significantly increased cost. Dr. Jonathan Genzen, ARUP’s chief medical officer and cohost of this episode, describes how laboratory professionals can provide public feedback to the FDA before the rule takes effect.
Related Information:
Dr. Ila Singh, chief of laboratory medicine at Texas Children’s Hospital, founded the Test Renaming for Understanding and Utilization in the Laboratory (TRUU-Lab) initiative several years ago to tackle challenges related to the nonstandardized and uninformative naming of laboratory tests. In this interview, Dr. Singh describes the surveys her CDC-funded collaborative has conducted with hundreds of physicians and other providers, and she shares insights about how to improve the ordering of tests through more effective naming.
Related Information:
Individuals pursue careers in academic medicine for many reasons. A love of organizational politics is rarely one of them, but faculty need to understand potential landmines if they are to avoid them. In this interview, Dr. Michael Cohen, a professor emeritus of pathology at Wake Forest University, draws on his experiences serving on faculty and in senior leadership at multiple institutions to explain how to thrive within the paradoxes of academic medicine.
Click here to listen to this episode on ARUP's website.
Related Information:
VIDEO LECTURE: A Discourse on Working in Academic Health Centers With Some Practical Observations by Michael B. Cohen, MD
Sustainability is a hot topic for American corporations, and health systems are no exception. In this interview, Glen Garrick, system sustainability director for Intermountain Healthcare, explains how his and other healthcare organizations are addressing their environmental, social, and governance responsibilities. He also describes how clinical laboratories can make the most positive impact.
Related Information:
New Building Embodies ARUP’s Commitment to Environmental Stewardship
ARUP’s Environmental Sustainability Efforts Pay Off
Recycling Coalition of Utah Names ARUP the Thomas A. Martin Business Recycler of the Year
Impressive New Structure Will Enhance ARUP’s Environmental Stewardship Efforts
Top 10 Ways ARUP Helps Our Environment
Click Here to Listen to This Episode from the ARUP Website
From the publisher's feed
Join Dr. Jon Genzen, professor of pathology with the Spencer Fox Eccles School of Medicine at the University of Utah and chief medical officer at ARUP Laboratories, as he explores the people,…

111,865 Listeners

48 Listeners